GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 64 filers reported holding GEMINI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $19,000 | +46.2% | 11,369 | +14.0% | 0.00% | – |
| Q1 2022 | $13,000 | -45.8% | 9,974 | +17.6% | 0.00% | -100.0% |
| Q4 2021 | $24,000 | -33.3% | 8,484 | -6.3% | 0.00% | 0.0% |
| Q3 2021 | $36,000 | -14.3% | 9,054 | +37.7% | 0.00% | 0.0% |
| Q2 2021 | $42,000 | -76.5% | 6,575 | -50.3% | 0.00% | -66.7% |
| Q1 2021 | $179,000 | – | 13,238 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 2,435,125 | $15,755,000 | 6.20% |
| Orbimed Advisors | 5,826,224 | $37,696,000 | 0.38% |
| Boxer Capital, LLC | 1,300,000 | $8,411,000 | 0.30% |
| Ikarian Capital, LLC | 426,455 | $2,759,000 | 0.22% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,135,000 | $13,813,000 | 0.21% |
| JS Capital Management LLC | 474,457 | $3,070,000 | 0.15% |
| HARVARD MANAGEMENT CO INC | 250,000 | $1,618,000 | 0.09% |
| Alyeska Investment Group, L.P. | 837,584 | $5,419,000 | 0.06% |
| Virtus ETF Advisers LLC | 19,673 | $127,000 | 0.05% |
| Caption Management, LLC | 384,900 | $2,488,000 | 0.03% |